🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
145.83
+0.24 (0.16%)
At close: Nov 20, 2026, 4:00 PM EST
147.88
+2.05 (1.41%)
After-hours: Nov 20, 2026, 7:50 PM EST

Guardant Health Revenue

Guardant Health had revenue of $360.98M in the quarter ending September 30, 2026, with 36.12% growth. This brings the company's total for the last twelve months to $1.28B, up 41.69% year-over-year. In the year 2025, Guardant Health had annual revenue of $982.02M with 32.88% growth. That makes Guardant Health the 6,637th largest company in the world by revenue and 1,635th in the United States.

Revenue (ttm)
$1.28B
Revenue Growth
+41.69%
P/S Ratio
15.43
Revenue / Employee
$510,329
Employees
2,506
Market Cap
19.73B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Oncology 683.60M 69.6%
  • Biopharma and Data 210.13M 21.4%
  • Screening 79.73M 8.1%
  • Licensing and Other 8.56M 0.9%

By Geography

Chart
  • United States 923.28M 94.0%
  • International 58.74M 6.0%
Fiscal year ended Dec 31, 2025 See the full Guardant Health breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025982.02M243.01M32.88%
Dec 31, 2024739.02M175.07M31.04%
Dec 31, 2023563.95M114.41M25.45%
Dec 31, 2022449.54M75.89M20.31%
Dec 31, 2021373.65M86.92M30.32%
Dec 31, 2020286.73M72.36M33.75%
Dec 31, 2019214.38M123.74M136.52%
Dec 31, 201890.64M40.80M81.85%
Dec 31, 201749.84M24.59M97.40%
Dec 31, 201625.25M--